Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 19, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12951-021-00768-w
Keywords
SARS-CoV-2; Nanobody; Spike; RBD; Pseudovirus neutralization
Funding
- National Natural Science Foundation of China [82073404, 81773188]
- Major Subject of the Science and Technology Department of Sichuan Province [2017SZ0015, 2017SZ0127, 2019YFS0330, 2019YFS0108]
- special research fund on COVID-19 of West China Hospital Sichuan University [HX-2019-nCoV-064, HX-2019-nCoV-058, HX-2019-nCoV-040]
Ask authors/readers for more resources
This study identified four specific nanobodies with antiviral activity against SARS-CoV-2 spike protein, with the heterodimer nanobody Nb91-Nb3-hFc showing the strongest RBD-binding affinity and neutralizing ability. The use of a naive VHH library could be a potential resource for rapid acquisition of antiviral nanobodies, with Nb91-Nb3-hFc showing potential as a therapeutic agent for COVID-19 treatment.
Background: The outbreak and pandemic of coronavirus SARS-CoV-2 caused significant threaten to global public health and economic consequences. It is extremely urgent that global people must take actions to develop safe and effective preventions and therapeutics. Nanobodies, which are derived from single-chain camelid antibodies, had shown antiviral properties in various challenge viruses. In this study, multivalent nanobodies with high affinity blocking SARS-CoV-2 spike interaction with ACE2 protein were developed. Results: Totally, four specific nanobodies against spike protein and its RBD domain were screened from a naive VHH library. Among them, Nb91-hFc and Nb3-hFc demonstrated antiviral activity by neutralizing spike pseudotyped viruses in vitro. Subsequently, multivalent nanobodies were constructed to improve the neutralizing capacity. As a result, heterodimer nanobody Nb91-Nb3-hFc exhibited the strongest RBD-binding affinity and neutralizing ability against SARS-CoV-2 pseudoviruses with an IC50 value at approximately 1.54 nM. Conclusions: The present study indicated that naive VHH library could be used as a potential resource for rapid acquisition and exploitation of antiviral nanobodies. Heterodimer nanobody Nb91-Nb3-hFc may serve as a potential therapeutic agent for the treatment of COVID-19.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available